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Abstract
1,10-Phenanthroline (phen) and metal–phen complexes display fungicidal and fungiststic activity, disrupt mitochondrial function
and induce oxidative stress. We have examined the effect of these drugs on the structure of yeast and mammalian cell organelles and
the integrity of cellular DNA. Exposure of Candida albicans to [Mn(phen)2(mal)].2H2O or [Ag2(phen)3(mal)].2H2O (mal
H2=malonic acid) resulted in DNA degradation whereas exposure to phen or [Cu(phen)2(mal)].2H2O did not. All drugs induced
extensive changes to the internal structure of yeast cells including retraction of the cytoplasm, nuclear fragmentation and disruption
of the mitochondrion. In the case of cultured mammalian cells [Cu(phen)2(mal)].2H2O induced apoptosis as evidenced by the ladder
pattern of DNA fragments following gel electrophoresis and also the blebbing of the cell membrane. The other drugs produced
non-specific DNA degradation in mammalian cells. In conclusion, phen and metal–phen complexes have the potential to induce
apoptosis in fungal and mammalian cells. Given their distinct mode of action compared to conventional anti-fungal drugs, phen
and metal–phen complexes may represent a novel group of anti-fungal agents for use either in combination with existing drugs or in
cases where resistance to conventional drugs has emerged.
# 2003 Published by Elsevier Ltd. OKeywords: Apoptosis; Candida; Metal-based drug; Fungicidal; FungistaticU
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C1. Introduction
Fungal pathogens are a serious cause of infection and
death in patients immuno-compromised as a result of
disease (e.g. leukaemia) or therapeutic procedures (e.g.
broad spectrum antibiotics, immuno-suppression prior
to organ transplantation) (De Pauw, 1997). The yeast
Candida albicans is an opportunistic fungal pathogen
which causes a range of diseases in susceptible indivi-
duals (Pfaller et al., 1998). These can range from super-
ficial infections involving the oral cavity, vagina or skin
to severe life-threatening infections involving manyessential organs. There has been a considerable increase
in the incidence of disease attributable to this yeast in
recent years with the spread of AIDS, the widespread
use of immuno-suppressive therapy and the prolonged
survival of patients with critical illnesses (Lunel et al.,
1999). Conventional therapy for the control of fungal
infections relies upon the use of polyene or azole drugs.
The most widely used polyene anti-fungal drug is
amphotericin B which functions by binding to ergos-
terol in the fungal cell membrane creating pores through
which intracellular constituents leak (Abu-Salah, 1996).
Azoles target the ergosterol biosynthetic pathway lead-
ing to cells depleted in ergosterol and with elevated
levels of toxic intermediates which prove fatal to the
cell. The emergence of C. albicans isolates resistant to
anti-fungal drugs has serious implications for the con-
tinued success of conventional anti-fungal therapy (Van
den Bossche et al., 1998; Kontoyiannis & Lewis, 2002).0887-2333/$ - see front matter # 2003 Published by Elsevier Ltd.
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Metal-based drugs represent a novel group of anti-
fungal agents with potential applications for the control
of fungal infections. 1,10-Phenanthroline (phen) and
substituted derivatives, both in the metal-free state and
as ligands co-ordinated to transition metals, disturb the
functioning of a wide variety of biological systems
(Butler et al., 1969). Furthermore, when the metal-free
N,N-chelating bases are found to be bioactive it is
usually assumed that the sequestering of trace metals is
involved, and that the resulting metal complexes are the
active species (MacLeod, 1952; Dwyer et al., 1969) Pre-
vious work has demonstrated that in RPMI medium at
37 C the metal-based drugs [Cu(phen)2(mal)].2H2O,
[Mn(phen)2(mal)].2H2O and [Ag2(phen)3(mal)].2H2O
(phen=1,10-phenanthroline; malH2=malonic acid)
inhibit the growth of C. albicans by around 95% at a
concentration of 5 mg/ml (Coyle et al., 2003). It was
established that both metal-free phen and the metal–
phen complexes affect mitochondrial function, retard
the synthesis of cytochromes b and c and uncouple
respiration. Treatment of fungal cells with the Cu(II)
and Ag(I) complexes resulted in a reduced amount of
ergosterol in the cell membrane and subsequent increase
in its permeability. Cells exposed to metal-free phen and
the Cu(II) and Mn(II) complexes [but not the Ag(I)
complex] demonstrated an elevation in oxygen uptake.
Indeed, part of the mode of action of this group of
drugs seems to lie in their ability to induce oxidative
stress within the cell as evidenced by the decreased
reduced:oxidized glutathione ratios (GSH:GSSG) and
increased levels of lipid peroxides in Candida cells trea-
ted with [Cu(phen)2(mal)].2H2O (McCann et al., 2000).
The aim of the work presented here was to further
characterise the mode of action of these drugs in terms
of their effects on the morphology of fungal and mam-
malian cells. Due to their different mode of action
compared to the polyene and azole anti-fungal drugs
(Coyle et al., 2003), metal based drugs may represent a
novel group of anti-fungal agents with potential appli-
cations either alone or in combination with conven-
tional anti-fungals. In addition, they may be applicable
in situations where resistance to conventional anti-fungal
drugs has emerged.2. Materials and methods
2.1. Fungal strain and culture conditions
C. albicans ATCC 10231 was obtained form the
American Type Culture Collection, (VA, USA). Cul-
tures were grown on Sabouraud dextrose agar (SDA)
plates at 37 C and maintained at 4 C for short-term
storage. Cultures were routinely sub-cultured every 4–6
weeks. Cultures were grown to the stationary phase
(approximately 1108/ml) overnight at 30 C and 200TE
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rpm in minimal medium (MM) [2% w/v glucose, 0.5%
w/v yeast nitrogen base (without amino acids or
ammonium sulphate), 0.5% w/v ammonium sulphate].
2.2. Human cell culture
The HEp-2 cell line (ATCC CCL23) was obtained
from the American Type Culture Collection (VA, USA)
and cells were grown in MEM (Sigma Aldrich Chemical
Co., Dorset, UK) supplemented with 5% v/v foetal calf
serum (Gibco, Paisley, UK), 4 mM l-glutamine and 1%
v/v Penn-Strep (Sigma Adrich). The DLKP cell line was
obtained from the National Cell and Tissue Culture
Centre (Dublin, Ireland) and is derived from a poorly
differentiated cell carcinoma from a lymph node meta-
stasis of a primary lung tumour. DLKP cells were cul-
tured under the same conditions as HEp-2 cells.
Adherent cells were grown in 80 cm2 culture flasks at
37 C and 5% CO2 in a humidified atmosphere and sub-
cultured by trypsinisation every 3–4 days.
2.3. Drugs
Chemicals were obtained from commercial sources
and used without further purification. [Cu(phen)2
(mal)].2H2O, [Mn(phen)2(mal)].2H2O and [Ag2(phen)3
(mal)].2H2O were prepared as previously described
(McCann et al., 2000).
2.4. In vitro toxicity testing
Sub-confluent DLKP cells were harvested by trypsi-
nisation washed and resuspended in PBS. Cells were
enumerated microscopically and diluted with MEM to
give a final cell density of 2104/ml. Ninety-six-well
plates (NUNC) were seeded with 100 ml of this suspen-
sion per well and incubated at 37 C and 5% CO2 in a
humidified atmosphere for 24 h to allow cell attach-
ment. Subsequently, a range of concentrations of metal
based drug was added to the rows of wells and the
plates were re-incubated until controls reached 80–90%
confluency (typically 5–6 days). Cell growth in toxicity
assays was quantified as described previously (Martin &
Clynes, 1993).
2.5. Extraction of DNA from C. albicans
Yeast cells were grown in the presence of drug (10 mg/
ml) to the late exponential phase (18–24 h) in MM at
30 C in an orbital incubator. Cells were harvested by
centrifugation and washed with 1 mm EDTA. Cells were
resuspended in spheroplasting buffer (1 M sorbitol, 0.1
M EDTA, 6 mg/ml lyticase and 0.05 M dithiotheritol,
pH 7.5) and incubated at 37 C for 2 h. Spheroplasts
were harvested by centrifugation, resuspended in lysing
buffer (50 mm EDTA, 50 mm Tris (pH 8), 1% w/v SDS2 B. Coyle et al. / Toxicology in Vitro& (&&&&)&–&1
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and 8 mg/ml proteinase K) and incubated at 65 C for
0.5 h. DNA was precipitated with two volumes of chil-
led ethanol (95% v/v) and incubated at 20 C over-
night. DNA was harvested by centrifugation, washed
with ethanol (20% v/v), harvested by centrifugation at
4000g for 25 min and allowed air dry. The DNA was
resuspended in TE buffer, 1 mg/ml RNase and incu-
bated at 37 C for 0.5 h. Ethanol (95% v/v) and 3 m
sodium acetate solution (pH 5.2) was added and the
sample stored at 20 C overnight.
2.6. Extraction of DNA from cultured human cells
Sub-confluent HEp-2 cells that had been cultured in
the presence of 3 mm of metal-based drug for 24 h were
harvested by trypsinisation, washed and resuspended in
PBS. Cells (1106) were resuspended in lysis buffer [20
mm EDTA, 0.8% (w/v) sodium lauryl sarcosiate, 100
mm Tris (pH 8.0)] and 10 mg/ml RNase (Boehringer
Manneheim, Sussex, UK) and incubated at 37 C for 18
h. Proteinase K (1 mg/ml) was subsequently added and
the samples were incubated for a further 2 h at 50 C.
2.7. DNA gel electrophoresis
Purity and concentration of DNA was determined by
UV spectroscopy (260–280 nm). DNA from yeast and
mammalian cells was run at a concentration of 40 mg/ml
on a 0.8% (w/v) agarose gel at 40 V for 18 h. Following
staining with ethidium bromide DNA was visualised
using a UV transilluminator.
2.8. Electron microscopy
Primary fixation of stationary phase yeast cells was in
a 3% solution of gluteraldehyde in 0.1 m phosphate
buffer for 2 h. Secondary fixation was in a 2% solution
of osmium tetroxide in 0.1 m phosphate buffer for 1 h.
Dehydration of samples was in an alcohol series of 10,
30, 50, 75, 95 and 100%, each for 15 min. Samples
were embedded in Agar 100 resin (Agar Scientific Ltd.,
UK) and viewed using a Hitachi H-7000 Transmission
Electron Microscope operating at 100 kv accelerating
voltage.3. Results
3.1. Determination of effect of metal-based drugs on
yeast cell DNA
The aim of the work presented here was to establish
whether drug-induced oxidative stress altered the struc-
ture of the cellular organelles and affected the integrity
of yeast DNA. The minimum inhibitory concentration
of each drug was used as determined previously (CoyleTE
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et al., 2003). Cells of C. albicans were grown to the sta-
tionary phase in MM containing 10 mg/ml of each drug
for 24 h. Cells were harvested by centrifugation, the
DNA was extracted as described and visualised by ethi-
dium bromide staining following agarose gel electro-
phoresis. The DNA extracted from yeast cells exposed
to [Ag2(phen)3(mal)].2H2O shows extensive degradation
(Fig. 1). Smaller amounts of degradation, as demon-
strated by smearing, are also visible in cells treated with
[Cu(phen)2(mal)].2H2O and [Mn(phen)2(mal)].2H2O,
whereas incubation of cells with metal-free phen causes
little or no DNA breakdown under the conditions
employed here.
3.2. Electron microscopic examination of C. albicans fol-
lowing growth in the presence of metal-based drugs
Cultures of C. albicans were grown to the stationary
phase overnight in MM medium at 30 C and 200 rpm
in the presence of each drug at a final concentration of
10 mg/ml. Cells were harvested by centrifugation,
washed with PBS (pH 7.2) and placed on ice prior to
preparation for TEM examination (as described). Cells
grown in the absence of drug showed normal cellular
morphology with a distinct cell wall, an intact nucleus
and numerous membranous organelles (Fig. 2a). In
contrast, cells grown in the presence of metal-free phen
demonstrated a distended cell wall, ruptured internal
organelles and the withdrawal of the cytoplasmic mem-
brane from within the cell wall (Fig. 2b). Cells treated
with [Ag2(phen)3(mal)].2H2O possessed a distended cell
wall, ruptured organelles and, in some cases, a frag-
mented nucleus (Fig. 2c). The most obvious feature of
[Cu(phen)2(mal)].2H2O-treated cells was the occurrenceFig. 1. DNA banding pattern of C. albicans cells treated with phen
and metal-phen complexes for 24 h. Lane 1: DNA from control cells,
Lane 2: phen, Lane 3: [Cu(phen)2(mal)].2H2O, lane 4: [Mn(phen)2(-
mal)].2H2O, Lane 5: [Ag2(phen)3(mal)].2H2O.B. Coyle et al. / Toxicology in Vitro& (&&&&)&–& 31
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shaped (Fig. 2d). With this drug the internal organelles
appeared intact but some shrinkage of the cytoplasm
within the cells was apparent. Cells exposed to
[Mn(phen)2(mal)].2H2O had, in most cases, completely
disrupted organelles. Some of these cells possessed
enlarged nuclei while others appeared to contain distinct
nuclear fragments (Fig. 2e).3.3. Effect of metal-based drugs on integrity of mamma-
lian DNA
Previous studies into the effect of metal-phen com-
plexes on fungal cell viability indicated that the drugs
disrupt mitochondrial function (Coyle et al., 2003). In
vitro toxicity assays were performed to establish the
concentration of 1,10-phen and [Cu(phen)2(mal)].2H2OO
FU
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Fig. 2. Electron-micrographs of C. albicans cells exposed to phen and metal-phen complexes for 24 h. (a) Control, (b) Phen, (c) [Ag2(phen)3
(mal)].2H2O, (d) [Cu(phen)2(mal)].2H2O, (e) [Mn(phen)2(mal)].2H2O. (Bar=1 mM).4 B. Coyle et al. / Toxicology in Vitro& (&&&&)&–&1
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capable of killing cultured human cells. The results
indicated IC50 values of 0.002 mg/ml and 0.001 mg/ml for
each drug, respectively against DLKP cells.
HEp-2 cells were chosen to determine whether the
metal–phen complexes induced apoptosis since the
appearance of the DNA fragmentation pattern asso-
ciated with this mode of cell death (Verhaegen, 1998) is
easier to visualise in this cell line than in the DLKP line.
HEp-2 cells were cultured for 24 h in the presence of 3
mm of metal-free phen or the Cu(II), Mn(II) and Ag(I)
phen complexes, and the DNA was subsequently
extracted and separated by agarose gel electrophoresis.
Degradation of high molecular weight DNA was evi-
dent in those cultures treated with Cu(II), Mn(II) and
Ag(I) phen. Cells treated with metal-free phen also
showed extensive degradation of DNA. Treatment of
cells with the copper–phen complex produced a DNA
pattern which was divided into distinct fragments. The
appearance of this DNA fragmentation ‘ladder’ is indi-
cative of apoptosis (or programmed cell death) occur-
ring in the cells in response to the metal based drug.
Cultures treated with Mn or Ag complexes demon-
strated DNA degradation but did not produce a specific
‘ladder’ fragmentation pattern at this concentration.
3.4. Microscopic examination of cultured human cells
grown in the presence of [Cu(phen)2(mal)].2H2O
Previous work has established that the metal-phen
complexes affect the oxygen uptake rate of C. albicans
and induced oxidative stress within the fungal cell
(McCann et al. 2000; Coyle et al., 2003). We sought to
determine whether these complexes affected the growth
and cellular morphology of cultured mammalian cells in
order to assess their toxicity in vitro towards cells
derived from human tissue.
In order to examine the morphological changes taking
place in cultured cells following exposure to the mostCO
F
toxic of the metal–phen complexes sub-confluent DLKP
cells were exposed to [Cu(phen)2(mal)].2H2O (3mM) and
incubated at 37 C for 48 h. Untreated cells show the
typical morphology of adherent epithelial cells (Fig. 4A).
Exposure to [Cu(phen)2(mal)].2H2O for 24 h produced
cells showing evidence of membrane ‘blebbing’
(Fig. 4b)— a feature of cell death by apoptosis (Ver-
haegen, 1998). After 48 h incubation a number of cells
had fragmented to give clusters of small sub-cellular
packets (Fig. 4c)— tentatively identified as apoptotic
bodies, a feature of the latter stages of apoptosis (Ver-
haegen, 1998).TE
D
PR
4. Discussion
The in vitro antibacterial action of phen has been
demonstrated on several species of bacteria (Dwyer et
al., 1969; Feeney et al., 1957). Whereas metal–phen
complexes can be bacteristatic (Dwyer et al., 1969) and
bactericidal (Butler et al., 1969) towards many Gram-
positive bacteria they are relatively ineffective against
Gram-negative organisms. In addition, dilute aqueous
solutions of phen and its Cu(II) and Mn(II) complexes
were highly toxic to clinical isolates of Candida species
(Geraghty et al., 2000; Geraghty et al., 1998).
Earlier in vitro experiments in our laboratories have
shown that phen and a number of transition metal
complexes incorporating this chelating ligand are extre-
mely active anti-fungal drugs (Geraghty et al.,
1999a,b,c; Devereux et al., 2000a,b; McCann et al.,
2000; Geraghty et al., 2000). The compounds have
minimum inhibitory concentrations in the range 1.25–
5.0 mg/ml and, at a concentration of 10 mg/ml, display
some fungicidal activity. Treating exponential and sta-
tionary phase yeast cells with phen and the Cu(II) and
Mn(II) complexes induces a dramatic increase in oxygen
consumption. All of the drugs cause reductions in the
levels of cytochromes b and c in the cells, while the
Ag(I) complex also lowers the amount of cytochrome
aa3. Cells treated with phen and the Cu(II) and Ag(I)
species show reduced levels of ergosterol while the
Mn(II) complex induces an increase in the sterol con-
tent. Extensive studies with [Cu(phen)2(mal)].2H2O
indicated that this drug induces significant cellular oxi-
dative stress (decreased reduced:oxidized glutathione
ratios (GSH:GSSG) and increased levels of lipid per-
oxides). Furthermore, as the drugs were not uniformly
active this suggested that their bioactivity has a degree
of metal-ion dependency. The drugs disrupt mitochon-
drial function, uncouple respiration and promote oxi-
dative stress in the organism (Coyle et al., 2003). As
such, phen and the metal–phen complexes may repre-
sent a novel set of highly active anti-fungal agents
whose mode of action is significantly different to that of
the polyene and azole prescription drugs.U
N
Fig. 3. DNA banding pattern from HEp-2 cells exposed to phen and
metal–phen complexes for 24 h. Lane 1: molecular weight standards,
Lane 2: control, Lane 3: phen, Lane 4: [Cu(phen)2(mal)].2H2O, lane 5:
[Mn(phen)2(mal)].2H2O, Lane 6: [Ag2(phen)3(mal)].2H2O.B. Coyle et al. / Toxicology in Vitro& (&&&&)&–& 51
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mechanistic studies and examines the effects of the
metal–phen complexes on the integrity of DNA and
cellular morphology of C. albicans and cultured mam-
malian cells. Exposing C. albicans to [Ag2(phen)3
(mal)].2H2O or [Mn(phen)2(mal)].2H2O leads to non-
specific DNA cleavage. In the case of the Mn(II) com-
plex this may be as a result of oxidative damage to the
cells caused by elevated levels of oxygen uptake (Coyle
et al., 2003). The Cu(II) complex and metal-free phen
seem to have little effect on fungal DNA. This latter
finding is surprising since phen and copper(I)–phen
complexes are known to cleave DNA with the same
preferences as micrococcal nuclease (Jessee et al., 1982;
Chen & Sigman, 1986). It is possible that either the
concentration used was not optimal to induce fungal
cell DNA degradation or that the cells were capable of
repairing the damage over the timeframe of the experi-
ment. In addition, it is possible that the oxidative stress
induced by these compounds can inhibit Caspase activ-
ity which is sensitive to the redox balance within the cell
(Green & Kroemer, 1998).
Electron-micrographic examination of fungal cells
exposed to phen and the metal–phen complexes reveals
severe disruption of internal cellular structures (Fig. 2a–e).C
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In particular, nuclear disruption is evident following
exposure to [Ag2(phen)3(mal)].2H2O [Mn(phen)2
(mal)].2H2O and [Cu(phen)2(mal)].2H2O. This is con-
sistent with the cleavage of fungal DNA evident in
Fig. 1. Nuclear fragmentation is characteristics of
apoptosis as is nuclear ‘crescent’ formation evident in
many cells (Cohen, 1993). Apoptosis in fungal cells fol-
lows many of the same steps evident in animal cells
including fragmentation of the nucleus, degradation of
DNA and disruption of internal organelles (Roze &
Linz, 1998). Discrete apoptotic bodies are not formed.
Exposure of mammalian cells to [Cu(phen)2
(mal)].2H2O at a concentration of 0.003 mg/ml results in
a DNA fragmentation pattern which is characteristic of
cells dying by apoptosis (Cohen, 1993; Verhaegen, 1998).
In this mode of cell death, the injured cell plays an active
role in its own demise and one part of the process is the
cleavage of nuclear DNA into specific sized fragments by
an endonuclease giving rise to a ‘ladder’ pattern of frag-
ments upon gel electrophoresis (Cohen, 1993; Cotter and
Al-Rubeai, 1995). Copper–phen complexes have pre-
viously been shown to induce apoptosis in a range of cell
lines (Zhou et al., 2002 a,b; De Vizcaya-Ruiz et al., 2002).
Exposure of cultured mammalian cells to metal-free phen,
[Ag2(phen)3(mal)].2H2O or [Mn(phen)2(mal)].2H2O didU
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Fig. 4. Micrographs of DLKP cells cultured in the presence of [Cu(phen)2(mal)].2H2O. (a) Cells showing membrane ‘blebbing’ after 24 h exposure,
(b) Apoptotic bodies after 48 h exposure, (c) Dead and detached cells after 96h exposure. (MB: membrane blebbing; AB: Apoptotic bodies). (Ori-
ginal magnification: (a) and (b) 400, (c) 100).6 B. Coyle et al. / Toxicology in Vitro& (&&&&)&–&1
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not give rise to a specific DNA fragmentation ladder
pattern but extensive non-specific DNA fragmentation
is visible. From this it is possible to conclude that
[Cu(phen)2(mal)].2H2O activates mammalian cell death
by apoptosis and that the other drugs induce non-spe-
cific cleavage of DNA possibly due to the nuclease-like
activity of the phen ligand (Jessee et al., 1982; Chen and
Sigman, 1986).
Examination of cultured mammalian cells exposed to
[Cu(phen)2(mal)].2H2O for 24 h show cells undergoing
membrane ‘blebbing’. After 48 h a number of cells were
observed to have undergone fragmentation to yield
structures tentatively identified as ‘apoptotic bodies’
(Fig. 4). These findings and the DNA degradation pat-
tern observed previously with this drug (Fig. 3) are
consistent with the induction of cell death by apoptosis
(Verhaegen, 1998). A similar finding was made by Viz-
caya-Ruiz et al. (2000) who demonstrated the ability of
copper based anti-cancer drugs to induce apoptosis in
human ovarian carcinoma cells. In that case the induc-
tion of apoptosis was monitored by changes in cell
morphology, activation of caspases and the degradation
of DNA to give a ladder pattern of fragments. Copper–
1,10-phenanthroline complexes have been shown to
induce G1-phase specific apoptosis in a liver carcinoma
cell line (Zhou et al., 2002a,b), further supporting the
view that the [Cu(phen)2(mal)].2H2O employed in this
work is capable of activating cell death by apoptosis.
Copper chelators have been shown to accumulate cop-
per within thymocytes which can trigger oxidative-stress
induced apoptosis (Nobel et al., 1995).
In conclusion, the metal-phen complexes examined
here have a potent anti-fungal effect being capable of
inhibiting growth of C. albicans by 95% at a concen-
tration of 5 mg/ml (Coyle et al., 2003). Yeast and mam-
malian cells exposed to these complexes at a
concentration of 10 mg/ml show DNA cleavage. In the
case of mammalian cells [Cu(phen)2(mal)].2H2O induces
a DNA fragmentation pattern indicative of apoptosis.
TEM examination of yeast cells reveals gross distortion
of cellular structures and nuclear fragmentation. This
work indicates that, in addition to its effect on mito-
chondrial function and oxygen uptake (Coyle et al.,
2003), [Cu(phen)2(mal)].2H2O also plays a role in indu-
cing cell death by apoptosis in yeast and mammalian
cells. The mitochondrion plays a central role in govern-
ing the induction of apoptosis (Green & Kroemer, 1998)
and the drugs examined here, particularly [Cu(phen)2
(mal)].2H2O, interfere with mitochondrial function
(Coyle et al., 2003) and integrity which may be sufficient
to push the cell towards apoptotic cell death. Whether
or not apoptosis is a direct effect of exposure to the
metal based drugs or is related to an effect on the mito-
chondrion induced by them (increased oxygen uptake,
disruption of cytochrome synthesis (Coyle et al., 2003)
is currently being investigated.O
F
The conventional polyene and azole anti-fungal drugs
target ergosterol in the fungal cell membrane or inhibit
ergosterol biosynthesis, respectively. We have demon-
strated that the metal–phen complexes examined here
have a distinct mode of action and may represent a
novel group of anti-fungal agents to be used alone or in
combination with existing anti-fungal drugs. In addi-
tion, metal-based drugs may offer the possibility of
over-coming the emerging problem of resistance to
conventional anti-fungal drugs (Van den Bossche et al.,
1998; Kontoyiannis & Lewis, 2002).R
O
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